{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:00:45Z","timestamp":1788476445244,"version":"build-2803163510"},"reference-count":232,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jconrel.2023.12.036","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T23:32:36Z","timestamp":1703892756000},"page":"65-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Protein and peptide-based renal targeted drug delivery systems"],"prefix":"10.1016","volume":"366","author":[{"given":"Jingyi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanrong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.12.036_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.addr.2017.12.019","article-title":"Targeting renal fibrosis: mechanisms and drug delivery systems","volume":"129","author":"Nastase","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0010","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","article-title":"Acute kidney injury","volume":"394","author":"Ronco","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0015","doi-asserted-by":"crossref","first-page":"16008","DOI":"10.1038\/nrdp.2016.8","article-title":"Kidney stones","volume":"2","author":"Khan","year":"2016","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0020","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/0929866525666180530123441","article-title":"Peptide and Low molecular weight proteins based kidney targeted drug delivery systems","volume":"25","author":"Xu","year":"2018","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.apsb.2013.12.005","article-title":"Kidney\u2013targeted drug delivery systems","volume":"4","author":"Zhou","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0030","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.4155\/fmc-2019-0152","article-title":"Renal targeting delivery systems","volume":"11","author":"Yuan","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/med.21532","article-title":"Targeting strategies for drug delivery to the kidney: from renal glomeruli to tubules","volume":"39","author":"Liu","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10611860701289875","article-title":"Randomly 50% N -acetylated low molecular weight chitosan as a novel renal targeting carrier","volume":"15","author":"Yuan","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0045","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1021\/acs.molpharmaceut.2c00401","article-title":"An albumin-enriched Nanocomplex achieves systemic delivery of Clopidogrel bisulfate to ameliorate renal ischemia reperfusion injury in rats","volume":"19","author":"Wu","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0050","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41551-018-0317-8","article-title":"DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury","volume":"2","author":"Jiang","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ijbiomac.2020.02.179","article-title":"Protein nanocomposites: special inferences to lysozyme based nanomaterials","volume":"151","author":"Sarkar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0060","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-022-00859-0","article-title":"Ferritin \u2013 a multifaceted protein scaffold for biotherapeutics","volume":"54","author":"Lee","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0305","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0310","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/1061186X.2017.1401076","article-title":"Novel advances in targeted drug delivery","volume":"26","author":"\u00d6zt\u00fcrk","year":"2018","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0315","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nnano.2017.170","article-title":"Glomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regime","volume":"12","author":"Du","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0320","article-title":"Organelle targeting: third level of drug targeting","volume":"585","author":"Padh","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0325","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41578-018-0038-3","article-title":"Transport and interactions of nanoparticles in the kidneys","volume":"3","author":"Du","year":"2018","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0330","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","article-title":"Improving kidney targeting: the influence of nanoparticle physicochemical properties on kidney interactions","volume":"334","author":"Huang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0335","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.copbio.2004.11.003","article-title":"In vivo molecular and cellular imaging with quantum dots","volume":"16","author":"Gao","year":"2005","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1152\/nips.01461.2003","article-title":"Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier","volume":"19","author":"Haraldsson","year":"2004","journal-title":"Physiology"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0065","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1172\/JCI127511","article-title":"The archaeal Dps nanocage targets kidney proximal tubules via glomerular filtration","volume":"129","author":"Uchida","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0070","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1039\/D1TB00234A","article-title":"Cytochrome C with peroxidase-like activity encapsulated inside the small DPS protein nanocage","volume":"9","author":"Waghwani","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0075","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1172\/JCI67867","article-title":"Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury","volume":"123","author":"Zarjou","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0080","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1159\/000508857","article-title":"Iron homeostasis and ferritin in sepsis-associated kidney injury","volume":"144","author":"McCullough","year":"2020","journal-title":"Nephron"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113892","article-title":"Ferritin nanocage: A promising and designable multi-module platform for constructing dynamic nanoassembly-based drug nanocarrier","volume":"176","author":"Zhang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.semnephrol.2020.01.007","article-title":"Ferritins in kidney disease","volume":"40","author":"McCullough","year":"2020","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0095","doi-asserted-by":"crossref","first-page":"F674","DOI":"10.1152\/ajprenal.00272.2006","article-title":"Statin-sensitive endocytosis of albumin by glomerular podocytes","volume":"292","author":"Eyre","year":"2007","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0100","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3892\/ijmm.2017.2902","article-title":"Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal fc receptor in glomerular podocytes","volume":"39","author":"Wu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1208\/s12249-020-01695-z","article-title":"Formulation, optimization, and evaluation of allopurinol-loaded bovine serum albumin nanoparticles for targeting kidney in Management of Hyperuricemic Nephrolithiasis: formulation, optimization, and evaluation of ABNPs for kidney targeting","volume":"21","author":"Kandav","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jconrel.2022.07.013","article-title":"Targeted delivery via albumin corona nanocomplex to renal tubules to alleviate acute kidney injury","volume":"349","author":"Qin","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijpharm.2013.10.041","article-title":"Peptide fragments of human serum albumin as novel renal targeting carriers","volume":"460","author":"Yuan","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejpb.2015.06.012","article-title":"Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin","volume":"94","author":"Yuan","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0125","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.biomaterials.2008.11.035","article-title":"The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells","volume":"30","author":"Zhang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0130","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1023\/A:1015835325321","article-title":"Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme","volume":"08","author":"Franssen","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0135","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1016\/0378-5173(92)90293-B","article-title":"Renal specific delivery of sulfamethoxazole in the rat by coupling to the low molecular weight protein lysozyme via an acid-sensitive linker","volume":"80","author":"Franssen","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0140","first-page":"251","volume":"12","year":"1996","journal-title":"Trends Genet."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0145","doi-asserted-by":"crossref","first-page":"F54","DOI":"10.1152\/ajprenal.00143.2016","article-title":"A kidney-selective biopolymer for targeted drug delivery","volume":"312","author":"Bidwell","year":"2017","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0150","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics11100542","article-title":"Utilizing a kidney-targeting peptide to improve renal deposition of a pro-angiogenic protein biopolymer","volume":"11","author":"Mahdi","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0155","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1159\/000511260","article-title":"Recovery of renal function following kidney-specific VEGF therapy in experimental renovascular disease","volume":"51","author":"Engel","year":"2020","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0160","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jconrel.2022.06.029","article-title":"Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy","volume":"348","author":"He","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0165","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.7150\/thno.37538","article-title":"Kidney-targeted rhein-loaded liponanoparticles for diabetic nephropathy therapy via size control and enhancement of renal cellular uptake","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jconrel.2023.04.042","article-title":"Kidney targeting peptide-modified biomimetic nanoplatforms for treatment of acute kidney injury","volume":"358","author":"Huang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0175","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/acs.bioconjchem.6b00057","article-title":"Renal targeting: peptide-based drug delivery to proximal tubule cells","volume":"27","author":"Wischnjow","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0180","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1021\/acs.bioconjchem.6b00397","article-title":"Drug conjugation affects pharmacokinetics and specificity of kidney-targeted peptide carriers","volume":"27","author":"Janzer","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0185","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/jpet.119.257022","article-title":"In vivo imaging of small molecular weight peptides for targeted renal drug delivery: A study in Normal and polycystic kidney diseased mice","volume":"370","author":"Lenhard","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12951-021-00900-w","article-title":"Tubule-specific protein nanocages potentiate targeted renal fibrosis therapy","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0195","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/bc300020f","article-title":"Peptide\u2013Drug Conjugate Linked via a Disulfide Bond for Kidney Targeted Drug Delivery","volume":"23","author":"Geng","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nucmedbio.2008.10.015","article-title":"Tumor targeting and SPECT imaging properties of an 111In-labeled galectin-3 binding peptide in prostate carcinoma","volume":"36","author":"Deutscher","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0022-3565(24)37071-5","article-title":"Biochemical characterization of the binding of echistatin to integrin alphavbeta3 receptor","volume":"283","author":"Kumar","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0210","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/ndt\/gfr603","article-title":"Beneficial effects of integrin v 3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis","volume":"27","author":"Amann","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0215","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1002\/smll.201200733","article-title":"Kidney podocytes as specific targets for cyclo(RGDfC)-modified nanoparticles","volume":"8","author":"Pollinger","year":"2012","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0220","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/acs.molpharmaceut.0c00094","article-title":"Cyclo-RGD truncated polymeric Nanoconstruct with Dendrimeric templates for targeted HDAC4 gene silencing in a diabetic nephropathy mouse model","volume":"18","author":"Raval","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0225","doi-asserted-by":"crossref","first-page":"2204626","DOI":"10.1002\/advs.202204626","article-title":"Renal endothelial cell-targeted extracellular vesicles protect the kidney from ischemic injury","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0230","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2017.09.072","article-title":"Polymeric microspheres for the sustained release of a protein-based drug carrier targeting the PDGF\u03b2-receptor in the fibrotic kidney","volume":"534","author":"Teekamp","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0235","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41467-022-28096-z","article-title":"A klotho-derived peptide protects against kidney fibrosis by targeting TGF-\u03b2 signaling","volume":"13","author":"Yuan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0240","doi-asserted-by":"crossref","first-page":"F554","DOI":"10.1152\/ajprenal.00391.2007","article-title":"Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes","volume":"294","author":"\u00c1sgeirsd\u00f3ttir","year":"2008","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/mol.107.034140","article-title":"Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium","volume":"72","author":"\u00c1sgeirsd\u00f3ttir","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0250","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/hc4201.097061","article-title":"Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin","volume":"104","author":"Lindner","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138870","article-title":"Targeting rapamycin to podocytes using a vascular cell adhesion Molecule-1 (VCAM-1)-harnessed SAINT-based lipid carrier system","volume":"10","author":"Visweswaran","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0260","article-title":"Endothelium-targeted delivery of dexamethasone by anti-VCAM-1 SAINT-O-Somes in mouse endotoxemia","volume":"13","author":"Li","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0265","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1002\/art.24026","article-title":"Anti-alpha 8 integrin Immunoliposomes: A novel system for delivery of therapeutic agents to the renal Glomerulus in systemic lupus erythematosus","volume":"58","author":"Scindia","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0270","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2147\/IJN.S347164","article-title":"Co-delivery of dexamethasone and captopril by \u03b18 integrin antibodies modified liposome-PLGA nanoparticle hybrids for targeted anti-inflammatory\/anti-fibrosis therapy of glomerulonephritis","volume":"17","author":"Zhou","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0275","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ki.2011.33","article-title":"A phase 1, single-dose study of fresolimumab, an anti-TGF-\u03b2 antibody, in treatment-resistant primary focal segmental glomerulosclerosis","volume":"79","author":"Trachtman","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0280","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1681\/ASN.2015111230","article-title":"Anti\u2013TGF-\u03b21 antibody therapy in patients with diabetic nephropathy","volume":"28","author":"Voelker","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0285","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1152\/ajpregu.00263.2011","article-title":"Renoprotective effects of anti-TGF-\u03b2 antibody and antihypertensive therapies in dahl S rats","volume":"303","author":"Murphy","year":"2012","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0290","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2215\/CJN.09321209","article-title":"Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria","volume":"5","author":"Adler","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0295","doi-asserted-by":"crossref","first-page":"F680","DOI":"10.1152\/ajprenal.00289.2015","article-title":"Human anti-\u03b13(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis","volume":"309","author":"Kvirkvelia","year":"2015","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0300","doi-asserted-by":"crossref","first-page":"9b00939","DOI":"10.1021\/acs.molpharmaceut.9b00939","article-title":"Antibody fragment F(ab\u2019)2 targeting Caveolae-associated protein PV1 for selective kidney targeting and retention","author":"Li","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0345","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1523-1755.1998.00797.x","article-title":"Size-selectivity of the glomerular barrier to high molecular weight proteins: upper size limitations of shunt pathways","volume":"53","author":"Tencer","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0350","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1021\/ar2003336","article-title":"Metabolism of nanomaterials in vivo: blood circulation and organ clearance","volume":"46","author":"Wang","year":"2013","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-9343(75)90533-1","article-title":"Renal handling of low molecular weight proteins","volume":"58","author":"Maack","year":"1975","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0360","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/ki.1978.41","article-title":"Glomerular filtration of proteins: clearance of anionic, neutral, and cationic horseradish peroxidase in the rat","volume":"13","author":"Rennke","year":"1978","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0365","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2022.01.033","article-title":"Renal Nano-drug delivery for acute kidney injury: current status and future perspectives","volume":"343","author":"Geo","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0370","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajps.2020.11.001","article-title":"Recent advances in nanotherapeutics for the treatment and prevention of acute kidney injury","volume":"16","author":"Yu","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0375","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2014.02.010","article-title":"The kidney and uremic toxin removal: Glomerulus or tubule?","volume":"34","author":"Masereeuw","year":"2014","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0380","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1681\/ASN.2014121193","article-title":"Tubular secretion in CKD","volume":"27","author":"Suchy-Dicey","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0385","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/IJNRD.S216673","article-title":"The importance of tubular function in chronic kidney disease","volume":"12","author":"Risso","year":"2019","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0390","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40262-017-0506-8","article-title":"Renal drug transporters and drug interactions","volume":"56","author":"Ivanyuk","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0395","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.mattod.2013.11.003","article-title":"Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology","volume":"16","author":"Liu","year":"2013","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0400","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Soo Choi","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0405","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/acsnano.5b05066","article-title":"Short- and long-term tracking of anionic Ultrasmall nanoparticles in kidney","volume":"10","author":"Liang","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0410","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1039\/C9BM01290G","article-title":"Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury","volume":"7","author":"Deng","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0415","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1021\/acsnano.5b02635","article-title":"CuS Nanodots with ultrahigh efficient renal clearance for positron emission tomography imaging and image-guided Photothermal therapy","volume":"9","author":"Zhou","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0420","first-page":"2639","article-title":"Shape effects of cylindrical versus spherical unimolecular polymer nanomaterials on in vitro and in vivo behaviors","author":"Zhang","year":"2019","journal-title":"Research"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0425","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.biomaterials.2004.09.015","article-title":"Liposome-encapsulated actin\u2013hemoglobin (LEAcHb) artificial blood substitutes","volume":"26","author":"Li","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0430","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","author":"Geng","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0435","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1021\/acsnano.7b00497","article-title":"Influence of size and shape on the anatomical distribution of endotoxin-free gold nanoparticles","volume":"11","author":"Talamini","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0440","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1158\/1535-7163.MCT-21-0116","article-title":"Imaging reveals importance of shape and flexibility for glomerular filtration of biologics","volume":"20","author":"Rafidi","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0445","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0450","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1039\/C9NR01120J","article-title":"A photo-inducible protein\u2013inorganic nanoparticle assembly for active targeted tumour theranostics","volume":"11","author":"Xie","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0455","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.colsurfb.2015.04.017","article-title":"Stable self-assembled nanostructured hen egg white lysozyme exhibits strong anti-proliferative activity against breast cancer cells","volume":"130","author":"Mahanta","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0460","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jconrel.2019.04.026","article-title":"Protein nanotubes as state-of-the-art nanocarriers: synthesis methods, simulation and applications","volume":"303","author":"Katouzian","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0465","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.foodhyd.2017.11.039","article-title":"Pullulan-based nanocomposite films for functional food packaging: exploiting lysozyme nanofibers as antibacterial and antioxidant reinforcing additives","volume":"77","author":"Silva","year":"2018","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0470","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.colsurfb.2016.07.005","article-title":"Production of lysozyme nanofibers using deep eutectic solvent aqueous solutions","volume":"147","author":"Silva","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0475","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1021\/acs.nanolett.0c03632","article-title":"Lysozyme membranes promoted by hydrophobic substrates for ultrafast and precise organic solvent Nanofiltration","volume":"20","author":"Wu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0480","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1002\/adma.201506476","article-title":"2D protein supramolecular Nanofilm with exceptionally large area and emergent functions","volume":"28","author":"Wang","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0485","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1080\/10408398.2014.993749","article-title":"Design of whey protein nanostructures for incorporation and release of nutraceutical compounds in food","volume":"57","author":"Ramos","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0490","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","article-title":"Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease","volume":"89","author":"Nielsen","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0495","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nrm778","article-title":"Megalin and cubilin: multifunctional endocytic receptors","volume":"3","author":"Christensen","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0500","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12195-020-00622-3","article-title":"Transdermal delivery of kidney-targeting nanoparticles using dissolvable microneedles","volume":"13","author":"Tripathy","year":"2020","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0505","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1021\/acsbiomaterials.9b00119","article-title":"Folate receptor-mediated renal-targeting Nanoplatform for the specific delivery of Triptolide to treat renal ischemia\/reperfusion injury","volume":"5","author":"Huang","year":"2019","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0510","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1039\/C8BM00813B","article-title":"An E-selectin targeting and MMP-2-responsive dextran\u2013curcumin polymeric prodrug for targeted therapy of acute kidney injury","volume":"6","author":"Hu","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0515","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1039\/D0BM00581A","article-title":"Sialic acid-modified dexamethasone lipid calcium phosphate gel core nanoparticles for target treatment of kidney injury","volume":"8","author":"Liu","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0520","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2007.03.011","article-title":"Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44","volume":"26","author":"Hidalgo","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0525","article-title":"Fucoidan-based micelles as P-selectin targeted carriers for synergistic treatment of acute kidney injury","volume":"32","author":"Shu","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0530","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11302-017-9558-3","article-title":"Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia\u2013reperfusion injury","volume":"13","author":"Sashindranath","year":"2017","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0535","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1172\/JCI119556","article-title":"Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment","volume":"100","author":"McEver","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0540","first-page":"39","article-title":"Identification of human cathelicidin peptide LL-37 as a ligand for macrophage integrin αMβ2 (Mac-1, CD11b\/CD18) that promotes phagocytosis by opsonizing bacteria","volume":"6","author":"Ugarova","year":"2016","journal-title":"Res. Rep. Biochem."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0545","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1038\/s41467-018-07506-1","article-title":"Cis interaction between sialylated Fc\u03b3RIIA and the \u03b1I-domain of mac-1 limits antibody-mediated neutrophil recruitment","volume":"9","author":"Saggu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0550","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.7150\/thno.54550","article-title":"Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury","volume":"11","author":"Cao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012800","article-title":"In vivo quantification of Vcam-1 expression in renal ischemia reperfusion injury using non-invasive magnetic resonance molecular imaging","volume":"5","author":"Akhtar","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0560","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/jpet.111.185579","article-title":"A fibrinogen-derived peptide provides intercellular adhesion Molecule-1-specific targeting and Intraendothelial transport of polymer Nanocarriers in human cell cultures and mice","volume":"340","author":"Garnacho","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0565","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1523-1755.1999.00662.x","article-title":"\u03b18 integrin in glomerular mesangial cells and in experimental glomerulonephritis","volume":"56","author":"Hartner","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0570","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4161\/cam.28988","article-title":"Fibrillin-1 and alpha8 integrin are co-expressed in the glomerulus and interact to convey adhesion of mesangial cells","volume":"8","author":"Marek","year":"2014","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0575","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.carbpol.2018.04.011","article-title":"CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage","volume":"193","author":"Hu","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0580","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biomaterials.2019.04.034","article-title":"Enhanced efficiency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes","volume":"211","author":"Liu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0585","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1681\/ASN.2019111160","article-title":"Multifunctional natural polymer nanoparticles as Antifibrotic gene carriers for CKD therapy","volume":"31","author":"Midgley","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0590","doi-asserted-by":"crossref","first-page":"eabb7422","DOI":"10.1126\/sciadv.abb7422","article-title":"ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0595","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1681\/ASN.2017010013","article-title":"Targeting anti\u2013TGF-\u03b2 therapy to fibrotic kidneys with a dual specificity antibody approach","volume":"28","author":"McGaraughty","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0600","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jconrel.2018.12.039","article-title":"The antifibrotic potential of a sustained release formulation of a PDGF\u03b2-receptor targeted rho kinase inhibitor","volume":"296","author":"Van Dijk","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0605","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jconrel.2017.11.029","article-title":"Pharmacokinetics of a sustained release formulation of PDGF\u03b2-receptor directed carrier proteins to target the fibrotic liver","volume":"269","author":"Van Dijk","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0610","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-019-0147-2","article-title":"VE-PTP phosphatase: a new target for diabetic kidney disease","volume":"15","author":"Allison","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0615","doi-asserted-by":"crossref","first-page":"F562","DOI":"10.1152\/ajprenal.2001.280.4.F562","article-title":"Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule","volume":"280","author":"Christensen","year":"2001","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0620","doi-asserted-by":"crossref","first-page":"F147","DOI":"10.1152\/ajprenal.00378.2013","article-title":"Megalin in acute kidney injury: foe and friend","volume":"306","author":"Mahadevappa","year":"2014","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0625","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1681\/ASN.2013010076","article-title":"Survivin mediates renal proximal tubule recovery from AKI","volume":"24","author":"Chen","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0630","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1097\/01.ASN.0000145013.44578.45","article-title":"Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated Lipocalin","volume":"15","author":"Mishra","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0635","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.msec.2017.05.068","article-title":"Efficient megalin targeted delivery to renal proximal tubular cells mediated by modified-polymyxin B-polyethylenimine based nano-gene-carriers","volume":"79","author":"Oroojalian","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0640","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jconrel.2020.05.033","article-title":"Megalin-targeting liposomes for placental drug delivery","volume":"324","author":"Alfaifi","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0645","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/antib8020030","article-title":"The ligands for human IgG and their effector functions","volume":"8","author":"De Taeye","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0650","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0711515105","article-title":"Podocytes use FcRn to clear IgG from the glomerular basement membrane","volume":"105","author":"Akilesh","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0655","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/imcb.12570","article-title":"Presence and possible impact of Fc\u03b3 receptors on resident kidney cells in health and disease","volume":"100","author":"Typiak","year":"2022","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0660","series-title":"Vitamins & Hormones","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0083-6729(08)00407-X","article-title":"Chapter 7 Exploitation of the Folate Receptor in the Management of Cancer and Inflammatory Disease","volume":"79","author":"Leamon","year":"2008"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0665","doi-asserted-by":"crossref","first-page":"C517","DOI":"10.1152\/ajpcell.00006.2004","article-title":"Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy","volume":"287","author":"Sandoval","year":"2004","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0670","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/CS20120198","article-title":"Inflammation and the pathogenesis of diabetic nephropathy","volume":"124","author":"Wada","year":"2013","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0675","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","article-title":"Targeting inflammation to treat diabetic kidney disease: the road to 2030","volume":"103","author":"Rayego-Mateos","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0680","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","article-title":"Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets","volume":"820","author":"Lv","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2180373","article-title":"Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome","volume":"2018","author":"Mihai","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0690","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneph.2014.114","article-title":"Inflammatory processes in renal fibrosis","volume":"10","author":"Meng","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.576463","article-title":"Autophagy and inflammation regulation in acute kidney injury","volume":"11","author":"Gong","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0700","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3892\/ijmm.2021.5018","article-title":"HO-1 knockdown upregulates the expression of VCAM-1 to induce neutrophil recruitment during renal ischemia-reperfusion injury","volume":"48","author":"He","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0705","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0710","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semnephrol.2018.10.007","article-title":"Kidney-immune system crosstalk in AKI","volume":"39","author":"Singbartl","year":"2019","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0715","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3389\/fphar.2019.01192","article-title":"Inflammation in renal diseases: new and old players","volume":"10","author":"Andrade-Oliveira","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0720","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1096\/fasebj.14.1.48","article-title":"Blocking P-selectin protects from ischemia\/reperfusion-induced acute renal failure","volume":"14","author":"Singbartl","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0725","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.4049\/jimmunol.1203179","article-title":"Integrin Regulation during Leukocyte Recruitment","volume":"190","author":"Herter","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0730","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/ki.1992.367","article-title":"Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis","volume":"42","author":"Wuthrich","year":"1992","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0735","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1182\/blood-2007-06-094565","article-title":"G\u03b1i2 is required for chemokine-induced neutrophil arrest","volume":"110","author":"Zarbock","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0740","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/01.RES.74.2.336","article-title":"Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage","volume":"74","author":"Kurose","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0745","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1159\/000358238","article-title":"Adhesion molecules involved in neutrophil recruitment during Sepsis-induced acute kidney injury","volume":"6","author":"Herter","year":"2014","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0750","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1046\/j.1523-1755.2000.00320.x","article-title":"Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture","volume":"58","author":"Sterzel","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0755","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1091\/mbc.9.6.1425","article-title":"Identification of Osteopontin as a Novel Ligand for the Integrin \u03b18\u03b21 and Potential Roles for This Integrin\u2013Ligand Interaction in Kidney Morphogenesis","volume":"9","author":"Denda","year":"1998","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0760","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/sdi.12705","article-title":"Acute kidney injury: epidemiology, outcomes, complications, and therapeutic strategies","volume":"31","author":"Negi","year":"2018","journal-title":"Semin. Dial."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0765","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40164-020-00192-0","article-title":"CD44 as a tumor biomarker and therapeutic target","volume":"9","author":"Xu","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0770","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s11255-009-9542-0","article-title":"CD44 expression in renal ischemia-reperfusion injury in rats","volume":"41","author":"Kocak","year":"2009","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0775","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005010054","article-title":"Protection against renal ischemia reperfusion injury by CD44 disruption","volume":"16","author":"Rouschop","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0780","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.0105-2896.2010.00903.x","article-title":"TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity","volume":"235","author":"Freeman","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0785","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.trsl.2014.07.010","article-title":"Therapeutic targets for treating fibrotic kidney diseases","volume":"165","author":"Lee","year":"2015","journal-title":"Transl. Res."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0790","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","article-title":"Targeting the renin-angiotensin-aldosterone system in fibrosis","volume":"91\u201392","author":"AlQudah","year":"2020","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0795","first-page":"48","article-title":"Transforming growth factor-beta and Smad signalling in kidney diseases","volume":"10","author":"Wang","year":"2005","journal-title":"Review Article. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0800","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-\u03b21\u2013induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0805","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1681\/ASN.2013070723","article-title":"Tet3-mediated Hydroxymethylation of epigenetically silenced genes contributes to bone Morphogenic protein 7-induced reversal of kidney fibrosis","volume":"25","author":"Tampe","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0810","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(03)15172-0","article-title":"CCN proteins: multifunctional signalling regulators","volume":"363","author":"Perbal","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0815","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2007111261","article-title":"CTGF inhibits BMP-7 signaling in diabetic nephropathy","volume":"19","author":"Nguyen","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0820","article-title":"The role of diabetes mellitus and hypertension in chronic kidney disease","author":"Ghaderian","year":"2014","journal-title":"Role Diabetes Mellit. Hypertens. Chronic Kidney Dis."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0825","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/jch.13672","article-title":"Prevalence and predictors of chronic kidney disease among Ghanaian patients with hypertension and diabetes mellitus: A multicenter cross-sectional study","volume":"21","author":"Tannor","year":"2019","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0830","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijcard.2014.03.085","article-title":"Endothelial function and cardiovascular events in chronic kidney disease","volume":"173","author":"Hirata","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0835","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0840","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","article-title":"Endothelium structure and function in kidney health and disease","volume":"15","author":"Jourde-Chiche","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0845","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s10157-013-0781-0","article-title":"Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease","volume":"17","author":"He","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0850","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bbagen.2010.05.010","article-title":"The ferritin-like superfamily: evolution of the biological iron storeman from a rubrerythrin-like ancestor","volume":"1800","author":"Andrews","year":"2010","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0855","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/molecules25040825","article-title":"Ferritin Nanocages for protein delivery to tumor cells","volume":"25","author":"Palombarini","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0860","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/cphc.201402722","article-title":"Self-assembled cage-like protein structures","volume":"16","author":"Putri","year":"2015","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0865","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2016.03.002","article-title":"Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer","volume":"107","author":"Truffi","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0870","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/adhm.201500389","article-title":"An Apoferritin-based drug delivery system for the tyrosine kinase inhibitor Gefitinib","volume":"4","author":"Kuruppu","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0875","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1021\/nn305791q","article-title":"RGD-modified Apoferritin nanoparticles for efficient drug delivery to tumors","volume":"7","author":"Zhen","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0880","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1021\/bm200026v","article-title":"pH-dependent structures of ferritin and Apoferritin in solution: disassembly and reassembly","volume":"12","author":"Kim","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0885","doi-asserted-by":"crossref","first-page":"14900","DOI":"10.1073\/pnas.1407808111","article-title":"H-ferritin\u2013nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection","volume":"111","author":"Liang","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100948","article-title":"A natural drug entry channel in the ferritin nanocage","volume":"35","author":"Jiang","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0895","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.3390\/ijms22137023","article-title":"Bioengineered ferritin Nanocarriers for Cancer therapy","volume":"22","author":"Sun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0900","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006964","article-title":"Something old, something new, something borrowed; how the Thermoacidophilic archaeon Sulfolobus solfataricus responds to oxidative stress","volume":"4","author":"Maaty","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0905","doi-asserted-by":"crossref","first-page":"10815","DOI":"10.1021\/bi060782u","article-title":"Structure of the DPS-like protein from Sulfolobus solfataricus reveals a Bacterioferritin-like Dimetal binding site within a DPS-like Dodecameric assembly","volume":"45","author":"Gauss","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0910","doi-asserted-by":"crossref","first-page":"12735","DOI":"10.1074\/jbc.R117.786632","article-title":"Iron transport proteins: gateways of cellular and systemic iron homeostasis","volume":"292","author":"Knutson","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0915","doi-asserted-by":"crossref","first-page":"19394","DOI":"10.1021\/acsnano.1c05891","article-title":"A Luminol-based self-illuminating Nanocage as a reactive oxygen species amplifier to enhance deep tumor penetration and synergistic therapy","volume":"15","author":"Xu","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0920","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2019.09.002","article-title":"Ferritin drug carrier (FDC) for tumor targeting therapy","volume":"311\u2013312","author":"He","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0925","article-title":"Self-oriented ferritin nanocages mitigate iron overload-induced oxidative stress for acute kidney injury","volume":"143227","author":"Lou","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0930","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","article-title":"Transferrin and transferrin receptors update","volume":"133","author":"Kawabata","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0935","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1073\/pnas.0913192107","article-title":"Binding and uptake of H-ferritin are mediated by human transferrin receptor-1","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0940","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1182\/blood-2009-05-224188","article-title":"Specific iron chelators determine the route of ferritin degradation","volume":"114","author":"De Domenico","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0945","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.apsb.2017.11.005","article-title":"Biomacromolecules as carriers in drug delivery and tissue engineering","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0950","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1080\/17425247.2016.1193149","article-title":"Albumin nanostructures as advanced drug delivery systems","volume":"13","author":"Karimi","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0955","series-title":"Advances in Protein Chemistry and Structural Biology","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.apcsb.2020.08.003","article-title":"Serum albumin: clinical significance of drug binding and development as drug delivery vehicle","volume":"123","author":"Tayyab","year":"2021"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0960","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijpharm.2015.02.018","article-title":"Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity","volume":"483","author":"Zhao","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0965","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb0970","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00280-001-0417-z","article-title":"A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy","volume":"49","author":"A., V.","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0975","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40591-016-0048-8","article-title":"Albumin-based drug delivery: harnessing nature to cure disease","volume":"4","author":"Larsen","year":"2016","journal-title":"Mol. Cell. Ther."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0980","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0049-3848(13)70150-6","article-title":"Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIII","volume":"131","author":"Schulte","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0985","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijpharm.2018.12.081","article-title":"Albumin fusion improves the pharmacokinetics and in vivo antitumor efficacy of canine interferon gamma","volume":"558","author":"Li","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0990","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3109\/10717544.2015.1048488","article-title":"Albumin corona on nanoparticles \u2013 a strategic approach in drug delivery","volume":"23","author":"Mariam","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.12.036_bb0995","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12272-020-01204-7","article-title":"Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy","volume":"43","author":"Lamichhane","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1000","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1039\/C5NR00211G","article-title":"A novel albumin nanocomplex containing both small interfering RNA and gold nanorods for synergetic anticancer therapy","volume":"7","author":"Choi","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1005","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.addr.2010.07.011","article-title":"Drug targeting to the kidney: advances in the active targeting of therapeutics to proximal tubular cells\u2606","volume":"62","author":"Dolman","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1010","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1053\/ajkd.2001.20733","article-title":"Mechanisms of albumin uptake by proximal tubular cells","volume":"37","author":"Brunskill","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1015","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.apsb.2019.11.012","article-title":"Effect of fluid shear stress on the internalization of kidney-targeted delivery systems in renal tubular epithelial cells","volume":"10","author":"Xu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1020","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2021.01.033","article-title":"Hyaluronic acid and albumin based nanoparticles for drug delivery","volume":"331","author":"Lei","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/00365517709101835","article-title":"Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids","volume":"37","author":"Mogensen","year":"1977","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4155\/tde.14.124","article-title":"Albumin: the next-generation delivery technology","volume":"6","author":"Howard","year":"2015","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jconrel.2011.08.041","article-title":"Imatinib-ULS-lysozyme: A proximal tubular cell-targeted conjugate of imatinib for the treatment of renal diseases","volume":"157","author":"Dolman","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3317\/jraas.2004.040","article-title":"Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis","volume":"5","author":"Windt","year":"2004","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2008.08.013","article-title":"Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors","volume":"132","author":"Fretz","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1055","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1080\/09205063.2012.759506","article-title":"Synthesis of low-molecular weight protein (LMWP) lysozyme\u2013curcumin conjugates for kidney drug targeting","volume":"24","author":"Wang","year":"2013","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12882-020-01833-6","article-title":"Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin","volume":"21","author":"Zheng","year":"2020","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1060","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-021-00242-0","article-title":"The glomerular filtration barrier: a structural target for novel kidney therapies","volume":"20","author":"Daehn","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/15419060009040302","article-title":"Distribution of \u03b1v\u03b2T3, \u03b1v\u03b2TB5 Integrins and the integrin associated protein \u2014 IAP (CD47) in human glomerular diseases","volume":"7","author":"Hafdi","year":"2000","journal-title":"Cell Adhes. Commun."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1096\/fj.14-258459","article-title":"Selective delivery of IFN-\u03b3 to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis","volume":"29","author":"Poosti","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1075","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1681\/ASN.2012080865","article-title":"Loss of klotho contributes to kidney injury by Derepression of Wnt\/\u03b2-catenin signaling","volume":"24","author":"Zhou","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1080","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1016\/j.ajpath.2015.08.004","article-title":"Klotho ameliorates kidney injury and fibrosis and normalizes blood pressure by targeting the renin-angiotensin system","volume":"185","author":"Zhou","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1085","article-title":"Identification of target-binding peptide motifs by high-throughput sequencing of phage-selected peptides","volume":"42","author":"Rentero Rebollo","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1090","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1007\/s00432-022-04515-y","article-title":"Nanobodies: a new potential for prostate cancer treatment","volume":"149","author":"Su","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/mabs.2.1.10786","article-title":"Antibody fragments: Hope and hype","volume":"2","author":"Nelson","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.04.012","article-title":"Complement activation by drug carriers and particulate pharmaceuticals: principles, challenges and opportunities","volume":"157","author":"Moghimi","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1105","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.addr.2011.06.002","article-title":"Material properties in complement activation","volume":"63","author":"Moghimi","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s42003-019-0337-2","article-title":"Targeted drug delivery via caveolae-associated protein PV1 improves lung fibrosis","volume":"2","author":"Marchetti","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1115","first-page":"268","article-title":"Peptide-based nanomaterials: self-assembly, properties and applications","volume":"11","author":"Li","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle\u2013liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1125","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1021\/acsnano.9b01383","article-title":"Elimination pathways of nanoparticles","volume":"13","author":"Poon","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1130","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-3659(99)00015-2","article-title":"Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution","volume":"59","author":"Ogawara","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2011.04.023","article-title":"Novel geometry type of nanocarriers mitigated the phagocytosis for drug delivery","volume":"154","author":"Lin","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.036_bb1145","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11095-008-9626-z","article-title":"Shape induced inhibition of phagocytosis of polymer particles","volume":"26","author":"Champion","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1150","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1242\/jcs.115.4.849","article-title":"Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target","volume":"115","author":"Beningo","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1155","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1002\/anie.201309464","article-title":"Polyethylene glycol backfilling mitigates the negative impact of the protein Corona on nanoparticle cell targeting","volume":"53","author":"Dai","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2023.12.036_bb1160","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1021\/la500057j","article-title":"Zwitteration: coating surfaces with Zwitterionic functionality to reduce nonspecific adsorption","volume":"30","author":"Schlenoff","year":"2014","journal-title":"Langmuir"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923008209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923008209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T21:31:40Z","timestamp":1738099900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923008209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":232,"alternative-id":["S0168365923008209"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.036","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein and peptide-based renal targeted drug delivery systems","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}